aspectsban.jpg (21183 bytes) Picture
 CLIP
HOME PAGE
 Skeleton & Bone
 Osteoporosis
 Clinical Measurement
 Bone Densitometry
 Links
Osteoporosis

What Is It?

Osteoporosis literally means ‘porous bone’. However, the term osteoporosis has been clinically defined as "a metabolic bone disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk".

In other words, osteoporosis is caused by low bone mass, as well as a weakened structure. Bones that were once strong enough to support our body become fragile and fracture more easily during daily activities such as bending to pick up a newspaper.

In fact most people don’t know that they have osteoporosis until they have had a fracture. Unfortunately, by this stage the disease is quite advanced. For this reason osteoporosis is often called the ‘silent disease’ because you do not feel any symptoms as your bones become weaker. Bone loss usually occurs slowly over time without symptoms, a bone breaking often being the first symptom of osteoporosis.

The consequences of osteoporosis are devastating. Each year in the United States the disease leads to a 1,500,000 fractures mostly of the hip, spine and wrist; in the United Kingdom there are more than 200,000 osteoporotic fractures per annum costing approximately £942m. This picture is much the same the world over.

What Happens & Why Measure It?

The remodelling process is under a complex control system involving several hormones including oestrogen, hyperthyroid hormone, calcitonin and Vitamin D.

At the menopause, there is a rapid fall in oestrogen levels which in turn creates a rapid loss of bone, particularly at sites of predominantly cancellous bone such as the spine, hip, wrist and heel. Osteoporosis may be caused by other 'secondary' factors such as rheumatoid arthritis and calcium malabsorption. A difficulty with rheumatoid arthritis is that one of the most popular forms of treatment, cortico-steroids, also tends to cause further osteoporosis. Disuse is also a cause of osteoporosis, which explains why older men may also suffer.

Multiple tiny compression fractures in the spine cause loss of height and the characteristic hunched back. If we stumble and put out our arm to break our fall, this could cause a fracture of the wrist (Colle’s fracture). As we get even older, our balance deteriorates and there is a tendency to fall more frequently, often onto our hips which may have been weakened by osteoporosis.

 

Who is at Risk and What Are The Risk Factors?

Osteoporosis is a complex disease and certain factors are linked to the development of osteoporosis. Hence people with these factors (sometimes called risk factors) are more likely to develop osteoporosis.

Gender: Women are more likely to develop osteoporosis than men, because of lower peak bone mass and accelerated bone loss after the menopause.
Age: The longer you live the greater the likelihood of developing osteoporosis, hence as an ageing population the figures for osteoporosis are on the increase.
Genetics: A person with family history of osteoporosis tends to have lower bone mass.
Body Size: Small-boned, thinner women and men are at a greater risk than heavier, big-boned people.
Ethnicity: Caucasians and Asians are at a significantly higher risk of developing osteoporosis than individuals of African heritage. Whilst the risk of fracture is lower for African American and Hispanic women, significant numbers of these women do develop osteoporosis.
Hormone levels: Early menopause, occurring naturally or surgically (via a hysterectomy and oophorectomy) can increase a woman’s likelihood of developing osteoporosis. Young women with abnormal absence of menstrual periods (amenorrhoea) during their childbearing years (e.g. athletes, ballet dancers) have thin bones. Also low testosterone levels in men can contribute to bone loss.
Diet: Inadequate calcium and vitamin D intake is deleterious to bone health while excessive consumption of other nutrients such as proteins, fibre and sodium can decrease calcium absorption.
Exercise: Bone is an active organ and responds to external stimuli, hence it is important to remain physically active throughout life.
Lifestyle options: Lifestyle habits like smoking and alcohol consumption are generally not good for healthy bones.
Medications: Long term use of certain medications can lead to bone loss. The following drugs are known to contribute to the development of osteoporosis: chronic corticosteroid therapy, excessive thyroid therapy, anticoagulants, chemotherapy, gonadotropin-releasing hormone and anti-convulsants.
Medical conditions: There are a variety of medical conditions that might impact the bone health, these include: anorexia nervosa, rheumatoid arthritis, amenorrhoea, hyperthyroidism, primary hyperparathyroidism, multiple myeloma, organ transplantation and chronic conditions such as kidney, lung or gastrointestinal diseases.

How may we Treat & Prevent Osteoporosis?

Osteoporosis Prevention

The primary aim of any intervention in osteoporosis is the prevention of fractures in individuals who have not yet fractured or the prevention of further progression of the disease in individuals with fragility fractures. Once an individual has developed osteoporosis, no drug therapy can restore depleted bone to the degree to which it might have been preserved by early preventive treatment. A good preventative strategy should start in childhood and continue throughout life. Regardless of age, adequate calcium intake along with regular exercise and appropriate levels of sex hormones are all required for good bone health and a strong skeleton.

Diet: Calcium is an essential ingredient of bone available either in a balanced diet or via supplements. Current thinking recommends optimal calcium intake to be 1000mg/day for post-menopausal women on ERT and 1500mg/day for those not on ERT. The recommendation for men (aged 25-65 years) is 1000mg/day. For men and women over 65 the calcium intake is recommended to be 1500mg/day. These guidelines are based on calcium in the diet (e.g. via dairy products) along with any supplements taken. Without Vitamin D the calcium cannot be taken up by the bone. There are many natural food sources of vitamin D, it can be taken in supplement form or manufactured in our skin on exposure to the sun.

There are currently different medications that have been approved by the FDA in America for osteoporosis prevention and/or treatment. In conjunction with your Physician you should decide which is most appropriate for you.

HRT: estrogen/oestrogen and hormone replacement therapy (ERT/HRT). In the short term HRT helps control hot flushes, vaginal dryness and other noticeable effects of estrogen loss. Over the long term, ERT prevents bone loss around the time of the menopause and in later life.  For women who still have a uterus, estrogen is generally prescribed with a second hormone, progestin/progesterone. This combination is referred to as hormone replacement therapy. ERT/HRT preparations include Premphase, Prempro, Premarin, Ogen, Estrace, Estratab and Estraderm. Consult your Physician for a brand which will suit your particular medical history.

SERMS: Selective Estrogen Receptor Modulators are being developed with the goal of eliminating the unwanted effects of HRT whilst maintaining their benefits to skeletal and cardiovascular systems (brand name Raloxifene)

Bisphosphonates; Alendronate sodium (brand name Fosamax) is the only non-hormonal medication currently approved for both the prevention and treatment of osteoporosis. It should be taken with adequate calcium and vitamin D.

Osteoporosis Treatment

When a person has already had one or more osteoporotic fractures, there are two main treatment goals: the first is to prevent further fractures and disability, and the second is to help the patient cope with pain and thereby improve quality of life. For an individual who has low bone mass but no fractures, the treatment goals are to prevent bone loss and avoid fractures altogether.

Most medications for osteoporosis are antiresorptives that work by slowing or stopping the action of bone cells called osteoclasts that break down and remove old bone tissue. The American Food and Drug Administration (FDA) currently has approved estrogen (ERT/HRT), salmon calcitonin (calsynar, miacalcin) and fosamax. There are many other experimental treatments that may prevent bone breakdown or stimulate the formation of new bone.

 

Next Section - Clinical Measurement

Chris Langton
Internet Publishing

Computer Simulation &
Modelling in Medicine

Aspects of Osteoporosis

Physical Measurement
of Bone

QUS Primer

Principles & Applications of Ultrasound

Medical Technology
Development

Site Contents

Contacts

e-mail.gif (4430 bytes)

CLIP

Please contact our Webmaster
with questions or comments.

Picture

Copyright 2000 Chris Langton Internet Publishing

MarbleBar2.jpg (1886 bytes)